CODY MYRICK: Open Payments
NPI 1043851801 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 69 payments from 15 companies in 2025. Trend: 2023 $1,869 · 2024 $1,343 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $289 |
| PFIZER INC. | 16 | $189 |
| Gilead Sciences, Inc. | 3 | $95 |
| Lilly USA, LLC | 4 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Novo Nordisk Inc | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Globus Medical, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: NURTEC ODT, VRAYLAR, UBRELVY, QULIPTA, MOUNJARO, Belbuca, Wegovy, Senza.
Industry payments across NC — which companies pay providers there.
